Fund profile
Morning Side
China
Leading
About
Morningside Group is a venture capital and private equity firm founded in 1986 and headquartered in Newton, Massachusetts. The firm focuses on investing in early-stage companies across various sectors, including biotechnology, consumer electronics, hardware, artificial intelligence, and fintech. Morningside is known for its long-term investment outlook and commitment to supporting innovative and impactful ventures. Notable investments in Morningside's portfolio include Cognoa, Sensel, The Nue Co., Homee, and Prescryptive Health. These investments highlight Morningside's focus on cutting-edge technology and healthcare solutions. The firm has made over 190 investments and has seen more than 30 successful exits, demonstrating its effectiveness in nurturing high-growth companies. Morningside operates globally, with significant investments in the United States and China, and has a diversified portfolio that includes companies like Evonetix in the biotech sector and Wiseconn in agtech. The firm is active in both seed and later-stage investments, providing substantial capital and strategic support to its portfolio companies.
Details
Highlights
$1.4M
Historical average check
$100M
Historical max check
April 2024
Last investment date
161
Investments
Fintech & Financial services
Agritech & Farming
Software & Apps
Pharma
Biotech
Other
Showing 0 lists